Genus plc (LON:GNS) was downgraded by analysts at Liberum Capital to a “hold” rating in a report released on Wednesday. They currently have a GBX 2,100 ($27.12) target price on the stock, up from their previous target price of GBX 1,950 ($25.18). Liberum Capital’s price target would suggest a potential upside of 6.11% from the company’s current price.
GNS has been the subject of several other research reports. Peel Hunt reiterated a “buy” rating and issued a GBX 2,600 ($33.58) price objective on shares of Genus plc in a research report on Monday, September 4th. Numis Securities Ltd reiterated a “hold” rating and issued a GBX 1,815 ($23.44) price objective on shares of Genus plc in a research report on Thursday, September 7th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of GBX 2,171.67 ($28.05).
Genus plc (LON:GNS) opened at 1979.00 on Wednesday. The company’s 50-day moving average price is GBX 1,812.35 and its 200 day moving average price is GBX 1,801.50. Genus plc has a 52 week low of GBX 1,652.00 and a 52 week high of GBX 2,113.00. The company’s market cap is GBX 1.21 billion.
About Genus plc
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with MarketBeat.com's FREE daily email newsletter.